Pacific Edge Sees Proposed 2027 Medicare Rate Increases Boosting Revenue, Margins

• Pacific Edge expects proposed Medicare prices of $1,026 for Cxbladder Monitor and $1,058 for Triage from January 1, 2027, pending finalization.
• Both tests currently receive $760; the proposed increases would support revenue, margins and commercial payer negotiations.
• Final Medicare coverage for Triage and Triage Plus remains expected before year-end 2026, enabling reimbursed volumes once effective.
• US commercial test volumes fell 13% to 2,867 in fiscal second-quarter 2027 as commercial spending remained constrained pending coverage.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacific Edge Limited published the original content used to generate this news brief on October 18, 2026, and is solely responsible for the information contained therein.